Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus

Código QR

Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus

Yinghua Li,1 Zhengfang Lin,1 Min Guo,1 Yu Xia,1 Mingqi Zhao,1 Changbing Wang,1 Tiantian Xu,1 Tianfeng Chen,2 Bing Zhu1 1Virus Laboratory, Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, 2Department of Chemistry, Jinan Univers...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Li Y, Lin Z, Guo M, Xia Y, Zhao M, Wang C, Xu T, Chen T, Zhu B
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	Selenium nanoparticles Oseltamivir Influenza virus Neuraminidase Apoptosis Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/a4288da65c1649c6b3957bcaee5a9e19
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Inhibition of H1N1 influenza virus-induced apoptosis by functionalized selenium nanoparticles with amantadine through ROS-mediated AKT signaling pathways
por: Li Y, et al.
Publicado: (2018)

Theoretical insights into the molecular mechanism of I117V mutation in neuraminidase mediated reduction of oseltamivir drug susceptibility in A/H5N1 influenza virus
por: Mohini Yadav, et al.
Publicado: (2021)

Restriction of H1N1 influenza virus infection by selenium nanoparticles loaded with ribavirin via resisting caspase-3 apoptotic pathway
por: Lin Z, et al.
Publicado: (2018)

Oseltamivir Is Effective against 1918 Influenza Virus Infection of Macaques but Vulnerable to Escape
por: Friederike Feldmann, et al.
Publicado: (2019)

Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin
por: Madhusudan Rajendran, et al.
Publicado: (2017)

NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
por: Florian Krammer, et al.
Publicado: (2018)

INFLUENZA VIRUS EPIDEMIOLOGICAL SITUATION IN THE SOUTH OF WESTERN SIBERIA IN 2011-2012
por: I. A. Sobolev, et al.
Publicado: (2012)

Isolation, sequencing and phylogenetic analysis of the hemagglutinin, neuraminidase and nucleoprotein genes of the Chilean equine influenza virus subtypes H7N7 and H3N8
por: Müller,Ilse, et al.
Publicado: (2005)

Influenza: reemergencia de una antigua enfermedad y el potencial riesgo de una nueva pandemia
por: Jofré M.,Leonor, et al.
Publicado: (2005)

Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies
por: Jin Gao, et al.
Publicado: (2019)

Cooperating H3N2 Influenza Virus Variants Are Not Detectable in Primary Clinical Samples
por: Katherine S. Xue, et al.
Publicado: (2018)

Mucosal Immunity against Neuraminidase Prevents Influenza B Virus Transmission in Guinea Pigs
por: Meagan McMahon, et al.
Publicado: (2019)

Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies
por: E. R. Job, et al.
Publicado: (2019)

Multifunctional selenium nanoparticles as carriers of HSP70 siRNA to induce apoptosis of HepG2 cells
por: Li Y, et al.
Publicado: (2016)

Uses of Selenium Nanoparticles in the Plant Production
por: Iqra Bano, et al.
Publicado: (2021)

THE CLINICAL AND LABORATORY EFFECTIVENESS OF OSELTAMIVIR FOR TREATMENT OF INFLUENZA IN HOSPITALIZED PATIENTS
por: L. V. Voloschcuk, et al.
Publicado: (2015)

THE STUDY OF INFLUENZA VIRUS NEURAMINIDASE HYDRATION DEGREE
por: N. S. Grebenkina, et al.
Publicado: (2018)

Influenza’s Newest Trick
por: Jeffery K. Taubenberger
Publicado: (2019)

Pre-Treatment with Zirconia Nanoparticles Reduces Inflammation Induced by the Pathogenic H5N1 Influenza Virus
por: Huo C, et al.
Publicado: (2020)

Influenza pandémica a un año de la primera ola: ¿Qué podemos decir ahora?
por: Perret P,Cecilia
Publicado: (2010)

Structure-Based Modification of an Anti-neuraminidase Human Antibody Restores Protection Efficacy against the Drifted Influenza Virus
por: Haihai Jiang, et al.
Publicado: (2020)

Selenium Nanoparticle Protection of Fibroblast Stress: Activation of ATF4 and Bcl-xL Expression
por: Chung S, et al.
Publicado: (2019)

Reduced Prescription of Baloxavir After Suspected Prevalence of a Baloxavir-Resistant Influenza Virus Strain and the Emergence of SARS-CoV-2 in a Tertiary Hospital in Japan
por: Kamioka Y, et al.
Publicado: (2020)

Selenium Nanoparticles Pre-Treatment Reverse Behavioral, Oxidative Damage, Neuronal Loss and Neurochemical Alterations in Pentylenetetrazole-Induced Epileptic Seizures in Mice
por: Yuan X, et al.
Publicado: (2020)

INDUCTION OF LONG-TERM T AND B CELL MEMORY IMMUNITY TO INFLUENZA A VIRUS (H5N1) IN PERSONS VACCINATED WITH LIVE INFLUENZA A VACCINE (H5N2)
por: I. V. Losev, et al.
Publicado: (2017)

Broad and Protective Influenza B Virus Neuraminidase Antibodies in Humans after Vaccination and their Clonal Persistence as Plasma Cells
por: Michael S. Piepenbrink, et al.
Publicado: (2019)

Rapid Detection of Ractopamine and Salbutamol in Swine Urine by Immunochromatography Based on Selenium Nanoparticles
por: Wang Z, et al.
Publicado: (2021)

Anticancer Activity of Biogenic Selenium Nanoparticles: Apoptotic and Immunogenic Cell Death Markers in Colon Cancer Cells
por: Katerina Spyridopoulou, et al.
Publicado: (2021)

Influenza Neuraminidase Characteristics and Potential as a Vaccine Target
por: Sarah Creytens, et al.
Publicado: (2021)

A Novel Neuraminidase-Dependent Hemagglutinin Cleavage Mechanism Enables the Systemic Spread of an H7N6 Avian Influenza Virus
por: Hyeok-il Kwon, et al.
Publicado: (2019)

Antioxidant and hepatoprotective role of selenium against silver nanoparticles
por: Ansar S, et al.
Publicado: (2017)

The Immunogenicity and Protective Efficacy of DNA Vaccine Coding For NA1 Gene of Highly Pathogenic Avian Influenza H5N1 Subtype
por: Soliman YA, et al.
Publicado: (2020)

Cytotoxicity of Selenium Nanoparticles in Rat Dermal Fibroblasts [Expression of Concern]
por: Ramos, et al.
Publicado: (2021)

Selenium as a pleiotropic agent for medical discovery and drug delivery
por: Guan BZ, et al.
Publicado: (2018)

Selenium Nanoparticles-Embedded Chitosan Microspheres and Their Effects Upon Alcohol-Induced Gastric Mucosal Injury in Rats: Rapid Preparation, Oral Delivery, and Gastroprotective Potential of Selenium Nanoparticles
por: Bai K, et al.
Publicado: (2020)

Novel walnut peptide–selenium hybrids with enhanced anticancer synergism: facile synthesis and mechanistic investigation of anticancer activity
por: Liao W, et al.
Publicado: (2016)

MORTALITY IN EXPERIMENTAL AND NATURAL INFECTION CAUSED BY HIGHLY PATHOGENIC INFLUENZA VIRUS H5N1
por: A. V. Zaykovskaya, et al.
Publicado: (2012)

Elemental Selenium Enriched Nanofiber Production
por: Khandsuren Badgar, et al.
Publicado: (2021)

siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy
por: Xia Y, et al.
Publicado: (2018)

Cytoprotective effects of cerium and selenium nanoparticles on heat-shocked human dermal fibroblasts: an in vitro evaluation
por: Yuan B, et al.
Publicado: (2016)